The safety of intravenous iron dextran in hemodialysis patients-Reference-Cited by-同舟云学术

The safety of intravenous iron dextran in hemodialysis patients

Published:1996-10 Issue:4 Volume:28 Page:529-534
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Fishbane Steven,Ungureanu Virgiliu-Dan,Maesaka John K.,Kaupke Charles J.,Lim Victoria,Wish Jay

Publisher

Elsevier BV

Subject

Nephrology

Reference14 articles.

1. Correction of anemia of end-stage renal disease with recombinant human erythropoietin: Results of a combined phase I and II clinical trial;Esbach;N Engl J Med,1987

2. Iron deficiency in patients with dialysis associated anemia during erythropoietin replacement therapy: Strategies for assessment and management;Van Wyck;Semin Nephrol,1989

3. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients;Fishbane;Clin Nephrol,1995

4. Intravenous iron dextran in clinical medicine;Hamstra;JAMA,1980

5. Low iron absorption in erythropoietin-treated hemodialysis patients;Kooistra;J Am Soc Nephrol,1995

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on iron supplementation in patients with cancer-related anemia;Expert Review of Hematology;2024-07-02

2. IV iron formulations and use in adults;Hematology;2023-12-08

3. Intravenous Iron Therapy: Re-administration after Prior Adverse Reaction;Korean Journal of Family Medicine;2023-11-20

4. Iron deficiency anemia among women: An issue of health equity;Blood Reviews;2023-11

5. Reducing unnecessary premedication prior to parenteral iron therapy: A quality improvement project;Transfusion;2023-08-16